- Biondvax Pharmaceuticals (NASDAQ:BVXV): Q3 EPS of -NIS0.02.
- Cash and cash equivalents of NIS15.09M.
- Press Release
Biondvax Pharmaceuticals reports Q3 results
This was corrected on 06/10/2022 at 8:12 AM. The original item reported incorrect EPS
Recommended For You
More Trending News
About SCNI Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SCNI | - | - |
| Scinai Immunotherapeutics Ltd. | ||